Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rodolfo Chicas Sett"'
Autor:
Juan Zafra, Juan Luis Onieva, Javier Oliver, María Garrido-Barros, Andrea González-Hernández, Beatriz Martínez-Gálvez, Alicia Román, Rafael Ordóñez-Marmolejo, Elisabeth Pérez-Ruiz, José Carlos Benítez, Andrés Mesas, Andrés Vera, Rodolfo Chicas-Sett, Antonio Rueda-Domínguez, Isabel Barragán
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4533 (2024)
Up to 80% of patients under immune checkpoint inhibitors (ICI) face resistance. In this context, stereotactic ablative radiotherapy (SABR) can induce an immune or abscopal response. However, its molecular determinants remain unknown. We present early
Externí odkaz:
https://doaj.org/article/db5ba8ef1f93461aabaa8b19946c07b0
Autor:
Rodolfo Chicas-Sett, Juan Castilla Martinez, Abrahan Hernández Blanquisett, Juan Zafra, Jorge Pastor-Peidro
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
The advent of targeted therapy has transformed the treatment paradigm and survival of patients with metastatic non-small cell lung cancer (NSCLC) with driver mutations. The development of acquired resistances during treatment with tyrosine kinase inh
Externí odkaz:
https://doaj.org/article/a34ed66a43744c97aae654393c0b59f4
Autor:
Rodolfo Chicas-Sett, Juan Zafra, Delvys Rodriguez-Abreu, Juan Castilla-Martinez, Gretel Benitez, Barbara Salas, Samuel Hernandez, Marta Lloret, Juan Luis Onieva, Isabel Barragan, Pedro C. Lara
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:655-665
The percentage of patients with metastatic non-small cell lung cancer (NSCLC) and melanoma who benefit from anti-programmed cell death protein 1 (anti-PD-1) is low owing to resistance mechanisms. SABR has a role in oligoprogressive disease and can im
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 9, Iss C, Pp 5-11 (2018)
Background: In the last years, limited studies have described that radiotherapy could produce important distant responses in unirradiated sites, the so-called “abscopal effect”. Recent evidence suggests that radiotherapy induces antigen release f
Externí odkaz:
https://doaj.org/article/04399b7b406e44789e8b0ce937cb5a91
Autor:
Rodolfo Chicas-Sett, Francisco Celada-Alvarez, Susana Roldán, Asunción Torregrosa, Jesus Betancourt, Juan Bautista-Ballesteros, Dolores Farga, Blanca Ibañez, Alejandro Tormo, Jose Perez-Calatayud
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 8, Iss 4, Pp 349-355 (2016)
Purpose : Groupe Européen de Curiethérapie (GEC) and European Society for Radiotherapy & Oncology (ESTRO) has proposed a rectal dose constraint of the most exposed 2-cc volume (D 2cc of ≤ 75 Gy EQD 2α/β = 3) during external- beam plus high-dose
Externí odkaz:
https://doaj.org/article/d82c0ee413804226821777151172100f
Autor:
Aurora Rodríguez Pérez, Enriqueta Felip Font, Rodolfo Chicas-Sett, Ángel Montero-Luis, Laura de Paz Arias, Aránzazu González-del-Alba, Fernando López-Campos, Carlos López López, Ovidio Hernando Requejo, Antonio José Conde-Moreno, José Ángel Arranz Arija, Javier de Castro Carpeño
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Oligometastatic disease (OMD) defines a cancer status that is intermediate between localized and widely spread metastatic disease, and can be treated with curative intent. While diagnostic imaging tools have considerably improved in recent years, uni
Autor:
Antonio José Conde-Moreno, Aránzazu González-del-Alba, Fernando López-Campos, Carlos López López, Ovidio Hernando Requejo, Javier de Castro Carpeño, Rodolfo Chicas-Sett, Laura de Paz Arias, Ángel Montero-Luis, Aurora Rodríguez Pérez, Enriqueta Felip Font, José Ángel Arranz Arija
Publikováno v:
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Oligometastatic disease (OMD) defines a status of cancer that is intermediate between localized and widely spread metastatic disease, and can be treated with curative intent. While imaging diagnostic tools have considerably improved in recent years,
Autor:
Rodolfo Chicas-Sett, Ignacio Morales-Orue, Juan Castilla-Martinez, Juan Zafra-Martin, Andrea Kannemann, Jesus Blanco, Marta Lloret, Pedro C Lara
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2173 (2019)
Background: Immune checkpoint inhibitors (ICI) have represented a revolution in the treatment of non-small-cell lung cancer (NSCLC). To improve these results, combined approaches are being tested. The addition of stereotactic ablative radiotherapy (S
Externí odkaz:
https://doaj.org/article/bd2370f7ef324e82a1fee47519ca4bd0
Autor:
Núria Rodríguez De Dios, Arturo Navarro-Martin, Cristina Cigarral, Rodolfo Chicas-Sett, Rafael García, Virginia Garcia, Jose Antonio Gonzalez, Susana Gonzalo, Mauricio Murcia-Mejía, Rogelio Robaina, Amalia Sotoca, Carmen Vallejo, German Valtueña, Felipe Couñago
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Non-small cell lung cancer (NSCLC) is a heterogeneous disease accounting for approximately 85% of all lung cancers. Only 17% of patients are diagnosed at an early stage. Treatment is multidisciplinary and radiotherapy plays a key role in all stages o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e359fd4364c939ecd1aca1bbcb643b72
http://hdl.handle.net/2445/186069
http://hdl.handle.net/2445/186069
Autor:
Carmen Beato Zambrano, Antonio Javier Jiménez López, Anna Librán Oriol, Gala Serrano Bermúdez, Oliver Higuera Gómez, Pilar Torres, Jose L. Perez, Almudena Sanz Yagüe, Alfredo Paredes Lario, Rodolfo Chicas Sett, Manuel Cobo Dols, Ibone Huerta González, María Isabel Blancas López-Barajas, Alexandra Giraldo Marín, Pedro Sánchez Mauriño, Luis Cabezón Gutiérrez, Diana Moreno Muñoz, Begoña Soler López, Ignacio Delgado Mingorance, Francisco Javier García Navalón
Publikováno v:
BMJ Supportive & Palliative Care
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
ObjectivesOpioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as efficacy and safety of naloxegol, in patients with cancer with OIC.MethodsAn observat